These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 24700157)
21. Update on the management of chronic kidney disease. Rivera JA; O'Hare AM; Harper GM Am Fam Physician; 2012 Oct; 86(8):749-54. PubMed ID: 23062158 [TBL] [Abstract][Full Text] [Related]
22. Progression of renal failure and lipids--is there evidence for a link in humans? Attman PO Nephrol Dial Transplant; 1998 Mar; 13(3):545-7. PubMed ID: 9550623 [No Abstract] [Full Text] [Related]
29. The axis AGE-RAGE-soluble RAGE and oxidative stress in chronic kidney disease. Gugliucci A; Menini T Adv Exp Med Biol; 2014; 824():191-208. PubMed ID: 25039001 [TBL] [Abstract][Full Text] [Related]
30. Role of Acid-Base Homeostasis in Diabetic Kidney Disease. Khairallah P; Scialla JJ Curr Diab Rep; 2017 Apr; 17(4):28. PubMed ID: 28343312 [TBL] [Abstract][Full Text] [Related]
31. Bariatric surgery and kidney disease outcomes in severely obese youth. Bjornstad P; Nehus E; van Raalte D Semin Pediatr Surg; 2020 Feb; 29(1):150883. PubMed ID: 32238288 [TBL] [Abstract][Full Text] [Related]
32. Alteration of lipid metabolism in chronic kidney disease, the role of novel antihyperlipidemic agents, and future directions. Sudhakaran S; Bottiglieri T; Tecson KM; Kluger AY; McCullough PA Rev Cardiovasc Med; 2018 Sep; 19(3):77-88. PubMed ID: 31054556 [TBL] [Abstract][Full Text] [Related]
33. Lipid lowering in liver and chronic kidney disease. Herrick C; Litvin M; Goldberg AC Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):339-52. PubMed ID: 24840263 [TBL] [Abstract][Full Text] [Related]
34. Correlations between plasma strontium concentration, components of calcium and phosphate metabolism and renal function in type 2 diabetes mellitus. van den Berkhof YS; Gant CM; Maatman R; De Graaf A; Navis GJ; Bakker SJL; Laverman GD Eur J Clin Invest; 2018 Sep; 48(9):e12987. PubMed ID: 29931675 [TBL] [Abstract][Full Text] [Related]
35. Cell adhesion molecule-1 shedding induces apoptosis of renal epithelial cells and exacerbates human nephropathies. Kato T; Hagiyama M; Takashima Y; Yoneshige A; Ito A Am J Physiol Renal Physiol; 2018 Mar; 314(3):F388-F398. PubMed ID: 29070574 [TBL] [Abstract][Full Text] [Related]
37. Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment. Fioretto P; Stefansson BV; Johnsson E; Cain VA; Sjöström CD Diabetologia; 2016 Sep; 59(9):2036-9. PubMed ID: 27306615 [No Abstract] [Full Text] [Related]
38. Renoprotective effect of myricetin restrains dyslipidemia and renal mesangial cell proliferation by the suppression of sterol regulatory element binding proteins in an experimental model of diabetic nephropathy. Kandasamy N; Ashokkumar N Eur J Pharmacol; 2014 Nov; 743():53-62. PubMed ID: 25240712 [TBL] [Abstract][Full Text] [Related]
39. Increased indoleamine 2,3-dioxygenase activity in type 2 diabetic nephropathy. Zhang Y; Ruan Y; Zhang P; Wang L J Diabetes Complications; 2017 Jan; 31(1):223-227. PubMed ID: 27646613 [TBL] [Abstract][Full Text] [Related]